The effects of a minidose of heparin on peritonitis in rats

Surgery, Gynecology & Obstetrics
|April 1, 1979
PubMed

Insights

Minidose heparin administration significantly improved survival rates in rats with peritonitis. This treatment reduced adhesions, abscesses, and bacterial recovery, suggesting a role in mitigating infection complications.

Area of Science:

  • Peritonitis and infection research
  • Pharmacological interventions in critical care

Background:

  • Peritonitis is a serious abdominal infection often leading to complications like adhesions, abscesses, and sepsis.
  • Current treatments focus on antibiotics and surgical intervention, but mortality remains significant.

Purpose of the Study:

  • To investigate the efficacy of minidose heparin in improving survival and reducing complications in a rat model of peritonitis.
  • To explore the potential mechanisms by which heparin might exert its effects in this context.

Main Methods:

  • Sprague-Dawley rats were induced with peritonitis and treated with subcutaneous or intraperitoneal minidose heparin.
  • Survival time, severity of adhesions and abscesses, and bacterial recovery from blood and peritoneal fluid were assessed.
  • Control groups received no heparin treatment.

Main Results:

  • Heparin treatment significantly increased survival time compared to controls.
  • Adhesions and abscesses were less severe and localized in heparin-treated rats.
  • A significant reduction in the recovery of viable bacteria from blood and peritoneal cavities was observed in the treatment groups.

Conclusions:

  • Minidose heparin demonstrates a protective effect in experimental peritonitis, enhancing survival and reducing infectious complications.
  • The observed benefits may stem from reduced fibrinogen deposition or enhanced fibrinolysis within the abdominal cavity.
  • Heparin represents a potential adjunctive therapy for peritonitis, warranting further investigation.

Related Concept Videos